A large majority of thyroid nodules are benign, and only 5\% have malignant features on cytological examination. Unfortunately, fine-needle aspiration is inconclusive in approximately 30\% of all thyroid biopsies, because the cytological features are indeterminate (suspicious for malignancy but not completely diagnostic or nondiagnostic). Wide panels of somatic mutations have been identified in thyroid cancers, and detection of genetic alterations in fine-needle aspirate has been demonstrated to improve diagnostic accuracy. Nevertheless, the relatively high number of genetic targets to be investigated, in comparison with the low percentage of malignant samples, makes the usual diagnostic protocol both time-consuming and expensive. We developed a reliable and sensitive protocol based on high-resolution melting analysis for the rapid screening of mutations of KRAS, HRAS, NRAS, and BRAF oncogenes in thyroid fine-needle aspirations. The entire procedure can be completed in approximately 48 hours, with a dramatic reduction in costs. The proposed protocol was applied to the analysis of 260 consecutive fine-needle aspiration biopsy (FNAB) samples. In 35 of 252 samples, 36 sequence variants were detected for BRAF (17 samples), NRAS (6 samples), HRAS (3 samples), KRAS codon 12 (9 samples), and KRAS codon 61 (1 sample).

A high-resolution melting protocol for rapid and accurate differential diagnosis of thyroid nodules / Irene Mancini; Pamela Pinzani; Cinzia Pupilli; Luisa Petrone; Maria Laura De Feo; Lapo Bencini; Mario Pazzagli; Gianni Forti; Claudio Orlando. - In: THE JOURNAL OF MOLECULAR DIAGNOSTICS. - ISSN 1525-1578. - ELETTRONICO. - 14:(2012), pp. 501-509. [10.1016/j.jmoldx.2012.03.003]

A high-resolution melting protocol for rapid and accurate differential diagnosis of thyroid nodules.

MANCINI, IRENE;PINZANI, PAMELA;PUPILLI, CINZIA;PETRONE, LUISA;BENCINI, LAPO;PAZZAGLI, MARIO;FORTI, GIANNI;ORLANDO, CLAUDIO
2012

Abstract

A large majority of thyroid nodules are benign, and only 5\% have malignant features on cytological examination. Unfortunately, fine-needle aspiration is inconclusive in approximately 30\% of all thyroid biopsies, because the cytological features are indeterminate (suspicious for malignancy but not completely diagnostic or nondiagnostic). Wide panels of somatic mutations have been identified in thyroid cancers, and detection of genetic alterations in fine-needle aspirate has been demonstrated to improve diagnostic accuracy. Nevertheless, the relatively high number of genetic targets to be investigated, in comparison with the low percentage of malignant samples, makes the usual diagnostic protocol both time-consuming and expensive. We developed a reliable and sensitive protocol based on high-resolution melting analysis for the rapid screening of mutations of KRAS, HRAS, NRAS, and BRAF oncogenes in thyroid fine-needle aspirations. The entire procedure can be completed in approximately 48 hours, with a dramatic reduction in costs. The proposed protocol was applied to the analysis of 260 consecutive fine-needle aspiration biopsy (FNAB) samples. In 35 of 252 samples, 36 sequence variants were detected for BRAF (17 samples), NRAS (6 samples), HRAS (3 samples), KRAS codon 12 (9 samples), and KRAS codon 61 (1 sample).
14
501
509
Irene Mancini; Pamela Pinzani; Cinzia Pupilli; Luisa Petrone; Maria Laura De Feo; Lapo Bencini; Mario Pazzagli; Gianni Forti; Claudio Orlando
File in questo prodotto:
File Dimensione Formato  
HRM thyroid.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 1.75 MB
Formato Adobe PDF
1.75 MB Adobe PDF Visualizza/Apri

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/969028
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact